Quantum-Si incorporated (QSI)

Market Cap	187.49M -18.8%
Revenue (ttm)	1.85M -46.2%
Net Income	-103.82M
EPS	-0.50
Shares Out	217.76M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,898,935
Open	0.8500
Previous Close	0.8539
Day's Range	0.8210 - 0.8665
52-Week Range	0.6912 - 3.1000
Beta	3.16
Analysts	Buy
Price Target	2.50 (+190.36%)
Earnings Date	May 7, 2026

About QSI

Quantum-Si incorporated, a life sciences company, develops proprietary, universal, and single-molecule detection platform applied to proteomics to enable next-gen protein sequencing (NGPS). The company offers Platinum and Platinum Pro NGPS instruments for single-molecule, amino acid level resolution, and automated data analysis; library preparation kits to prepare a customer’s protein sample for sequencing; and sequencing kits, which contain the reagents and consumables used to perform NGPS. It also provides Platinum analysis software, a cloud-...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2013
• Employees: 145
• Stock Exchange: NASDAQ
• Ticker Symbol: QSI
• Website: https://www.quantum-si.com

Financial Performance

In 2025, Quantum-Si incorporated's revenue was $2.44 million, a decrease of -20.34% compared to the previous year's $3.06 million. Losses were -$101.34 million, 0.33% more than in 2024.

Analyst Summary

According to 3 analysts, the average rating for QSI stock is "Buy." The 12-month stock price target is $2.5, which is an increase of 190.36% from the latest price.

Price Target

$2.5

(190.36% upside)

Analyst Consensus: Buy